Taiming Biotech - Market Research on Human Fibrinogen and Human Prothrombin Complex
Company overview
Shandong Taiming Biotech Products Co., Ltd. is a nationally recognized high-tech enterprise specializing in the R&D and production of blood products, with annual sales reaching RMB 6 billion. The company is committed to addressing the significant gap in China's blood product supply, offering a range of products including human fibrinogen, human prothrombin complex, human serum albumin, intravenous immunoglobulin, and human factor VIII. Taiming's blood products are widely adopted across major hospitals in China and have been clinically validated, with broad product coverage and strong potential for future market expansion...
Research background
Currently, Taiming Biotech's products such as human fibrinogen and human prothrombin complex have been introduced into nearly all hospitals across China and are widely used in clinical practice. However, in the face of competition from alternative products and other branded alternatives, Taiming's market share still faces room for growth. To accurately capture market demand, Taiming has decided to further understand the prescribing behaviors and medication preferences of physicians across different regions, hospitals, and specialties, in order to support more targeted marketing and market expansion strategies.
Research scope
In October 2020, Taiming Biotech commissioned CEIDEA Research to conduct a nationwide survey utilizing big data resources from a physician database. The study involved approximately 500 physicians, collecting in-depth insights into medication usage scenarios, prescribing preferences, and specific needs across various medical specialties. The research also examined differences in product usage patterns among different geographic regions, hospital types, and physician groups, with particular focus on the demand ratios for Taiming's products across nine key specialties, as well as variations in prescribing thresholds among different physicians.
Expected outcomes
This research will provide Taiming Biotech with critical market data to better understand the medication needs and preferences of hospitals, regions, and specialties. The findings will support the optimization of marketing and promotion strategies. The report will serve as a decision-making basis for Taiming to accurately identify high-potential specialty channels, and to develop effective market expansion and product improvement strategies. By deeply analyzing market demand and physician prescribing behaviors, Taiming will be better positioned to enhance its market share and strengthen the competitiveness of its products.
Scan to add our research consultant